Company Description
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices.
The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
It also develops System-on-a-Chip (SoC), for blood pressure or continuous glucose monitoring (CGM) systems.
The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018.
Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
| Country | United States |
| Founded | 2018 |
| IPO Date | Mar 23, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Dr. John Mastrototaro Ph.D. |
Contact Details
Address: 6800 Koll Center Parkway Pleasanton, California 94566 United States | |
| Phone | 408-393-1209 |
| Website | movano.com |
Stock Details
| Ticker Symbol | MOVE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001734750 |
| CUSIP Number | 62459M107 |
| ISIN Number | US62459M1071 |
| Employer ID | 82-4233771 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. John Mastrototaro Ph.D. | Chief Executive Officer, President and Director |
| Michael Aaron Leabman | Founder, Chief Technology Officer and Director |
| Jeremy Cogan C.F.A. | Chief Financial Officer and Secretary |
| Tyla Bucher | Chief Marketing Officer |
| Phil Kelly | Senior Vice President of Engineering |
| Stacy Salvi | Vice President of Strategy |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 17, 2024 | PRE 14A | Other preliminary proxy statements |
| May 17, 2024 | 10-Q | Quarterly Report |
| May 15, 2024 | 8-K | Current Report |
| May 15, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 8, 2024 | 424B7 | Filing |
| May 7, 2024 | EFFECT | Notice of Effectiveness |
| Apr 29, 2024 | 10-K/A | [Amend] Annual report |
| Apr 23, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 17, 2024 | D | Notice of Exempt Offering of Securities |
| Apr 16, 2024 | 10-K | Annual Report |